Table 1. Sex- and age-specific prevalences of anti-HCV antibody in hemodialysis patients and a general population.
| Age group | General population | HD patients | ||
| Total No. |
HCV Ab-positive (%) |
Total No. |
HCV Ab-positive (%) |
|
| Men | ||||
| 20–39 | 36 | 0 (0.0%) | 52 | 4 (7.7%) |
| 40–49 | 890 | 16 (1.8%) | 96 | 13 (13.5%) |
| 50–59 | 1564 | 14 (0.9%) | 191 | 38 (19.9%) |
| 60–69 | 3001 | 43 (1.4%) | 233 | 27 (11.6%) |
| ≥70 | 2159 | 50 (2.3%) | 207 | 15 (7.2%) |
| total | 7650 | 123 (1.6%) | 779 | 97 (12.5%) |
| Women | ||||
| 20–39 | 62 | 0 (0.0%) | 22 | 0 (0.0%) |
| 40–49 | 2662 | 22 (0.8%) | 55 | 5 (9.1%) |
| 50–59 | 3980 | 40 (1.0%) | 121 | 5 (4.1%) |
| 60–69 | 4927 | 87 (1.8%) | 116 | 1 (0.9%) |
| ≥70 | 3193 | 82 (2.6%) | 121 | 11 (9.1%) |
| total | 14 824 | 231 (1.6%) | 435 | 37 (8.5%) |
Abbreviations: HCV, hepatitis C virus; HD, hemodialysis; No., number; Ab, antibody.